Niu, Y., Lin, A., Luo, P., Zhu, W., Wei, T., Tang, R., . . . Zhang, J. (2020). Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors. Front Pharmacol.
Citação norma ChicagoNiu, Yuchun, Anqi Lin, Peng Luo, Weiliang Zhu, Ting Wei, Ruixiang Tang, Linlang Guo, e Jian Zhang. "Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors." Front Pharmacol 2020.
Citação norma MLANiu, Yuchun, et al. "Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors." Front Pharmacol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.